| 产品详情 |
| Edit |   |
|---|
| Product Name | CD1530 |
|---|
| Description | Purity >97%. CD1530 is a selective retinoic acid receptor (RAR gamma) agonist (Kds = 150, 1,500, and 2,750 nM for RAR gamma, RAR beta, and RAR alpha receptors, respectively). It demonstrates transcriptional activity at RAR gamma with an AC50 value of 1.8 nM. It has been used in combination with bexarotene, a retinoid X receptor agonist, to inhibit oral carcinogenesis induced by the carcinogen 4-nitroquinoline 1-oxide in a mouse model of human oral-cavity and esophageal squamous-cell carcinoma. |
|---|
| Size | n/a |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | 4-(6-hydroxy-7-tricyclo[3.3.1.13,7]dec-1-yl-2-naphthalenyl)-benzoic acid |
|---|
| Gene, Accession, CAS # | CAS: 107430-66-0 |
|---|
| Catalog # | LS-H153 |
|---|
| Price | |
|---|
| Order / More Info | CD1530 from LIFESPAN BIOSCIENCES INC. |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|